P-31 SHORT-TERM EFFICACY AND SAFETY OF LOLA THERAPY IN PATIENTS WITH CIRRHOSIS AND MINIMAL HEPATIC ENCEPHALOPATHY: A REAL-LIFE COHORT STUDY Fátima Higuera-De La Tijera; AB Moreno-Cobos; Christian Hinojosa-Segura; Diana Montemira-Orozco; Imran Cruz-Reyes; Juana Zavala-Ramírez; Daniel Santana-Vargas; Alfredo Servín-Caamaño; Juan Miguel Abdo-Francis; José Luis Pérez-Hernández;

O-33 PREVALENCE OF HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS ACCORDING TO THE FAST® INDEX IN A GROUP OF DIABETIC PATIENTS Andrés Burak-Leipuner; Fatima Higuera-de la Tijera; Alfredo Servín-Caamaño; Javier Romero-Bermúdez; Laura Ceceña-Martínez; Felix García-Gorrosquieta; Kevin Vázquez-Hernández; Nidia Uribe-Rivera; Pablo Alagón-Fernández del Campo; Farid Vargas-Duran; Christian Hinojosa-Segura; Diana Montemira-Orozco; José Luis Pérez-Hernández;

P-37 ASSESSMENT OF METABOLIC ASSOCIATED FATTY LIVER DISEASE, ALCOHOLIC LIVER DISEASE, AND DUAL DAMAGE IN APPARENTLY HEALTHY BLOOD BANK INDIVIDUALS Jorge Emilio Lira-Vera; O Morales-Gutiérrez; Farid Yael Vargas-Durán; Pablo Alagón-Fernández Del Campo; Ana Karen Soto Martínez; Diana Montemira-Orozco; Andrés Burak-Leipuner; Christian Hinojosa-Segura; Gabriela Gutiérrez-Reyes; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María De Los Ángeles Lemus-Peña; Daniel Montes De Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; María De Fátima Higuera-De La Tijera; Yadira Lilian Béjar-Ramírez; José Luis Pérez-Hernández;